After a research journey spanning over five years, the trio was recently awarded two patents, numbered 482082 and 483371. The patented compound demonstrated efficacy against Plasmodium falciparum species, the most dangerous strain of malaria parasite. Their effectiveness surpasses that of existing market-available quinine, a significant breakthrough in addressing the alarming rise of drug-resistant malaria strains.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment